In recent years, significant strides have been made in the realm of medical imaging, ushering in a new era of possibilities for healthcare professionals engaged in diagnosing, treating, and monitoring a diverse array of medical conditions and diseases. The convergence and developments in the state-of-the-art techno...
Find MoreSchizophrenia and Bipolar disorder (BD) are most of the times difficult to distinguish. Schizophrenia is characterized by hallucinations, and delusions when a patient loses reality and feels detached. On the other hand, Bipolar disorder a person suffers from extreme phases of mood swings from sometimes depression t...
Find MoreData from three cohorts of patients with early stage pancreatic ductal adenocarcinoma (PDAC) indicate that a two-protein biomarker panel, consisting of plasma tissue factor pathway inhibitor (TFPI) and tenascin-C (TNC-FN-III-C), as measured in plasma samples using an ELISA improves the prognostic value of CA 19-9. T...
Find MoreData from three cohorts of patients with early stage pancreatic ductal adenocarcinoma (PDAC) indicate that a two-protein biomarker panel, consisting of plasma tissue factor pathway inhibitor (TFPI) and tenascin-C (TNC-FN-III-C), as measured in plasma samples using an ELISA improves the prognostic value of CA 19-9. T...
Find MoreOncoTrack, a public-private consortium supported by the Innovative Medicines Initiative (IMI) joint undertaking, has conducted one of Europe’s largest collaborative academic-industry research projects to develop and assess novel approaches for identification of new markers for colon cancer. Scientists from the OncoT...
Find MoreLive Coverage of ASCO 2024 Visit Now for Real-Time Insights and Analytical, Impactful Updates!